The Study of the Relationship of Procalcitonin (PCT) Levels and C-Reactive Protein (CRP) Levels in Patients Diagnosed by a Doctor Who is Infected with COVID-19, Phra Nakhon Si Ayutthaya Hospital in 2021
Keywords:
COVID-19, procalcitonin, C-reactive proteinAbstract
Objective: The Study of the relationship of procalcitonin (PCT) levels and C-reactive protein (CRP) levels and study of procalcitonin levels and C-reactive protein levels in pneumonia and nonpneumonia and secondary bacterial infection in COVID-19 case. Methods: This retrospective study of 383 COVID-19 patients was conducted in Phra Nakhon Si Ayutthaya hospital between 1st July and 30th November 2021. Patient background, clinical aboratory with focus on PCT and CRP level. Statistics using general data are number, maximum and minimum, percentage, mean, standard deviation. Studies on the relationship of Procalcitonin (PCT) levels and C-reactive protein (CRP) levels. Statistical compairsons were performed using Chi-Square Test, Fisher's Exact and Independent t-test. A p-value<0.05 was considered statisfically significant. Results: Higher age and PCT levels were associated with patients infected with COVID-19 were statistically significant (p<0.05) and the mean of CRP of PCT< 0.25 ng/ml (58.09) was lower than PCT≥0.25 ng/ml (91.47) were statistically significant (p<0.05). COVID-19 patients presented with secondary bacterial infection in sputum culture 43 patients (11.2%) and blood culture 55 patients (14.4%). conclusion: Higher age and higher PCT levels were associated with patients infected with COVID-19 and low procalcitonin can reduce unnecessary CRP measurement and guiding the use of antibiotic therapy.
References
กรมวิทยาศาสตร์การแพทย์. คู่มือการตรวจวินิจฉัยโรคติดเชื้อไวรัสโคโรนา 2019 ทางห้องปฏิบัติการ SARS-CoV-2. นนทบุรี : กรมวิทยาศาสตร์การแพทย์; 2564.
Pink I, Raupach D, Fuge J, Vonberg RP, Hoeper MM, Welte T, et al. C-reactive protein and procalcitonin for antimicrobial stewardship in COVID-19. Infection 2021;49(5):935-43.
Yegenaga I, Hoste E, Van Biesen W, Vanholder R, Benoit D, Kantarci G, et al. Clinical characteristics of patients developing ARF due to sepsis/systemic inflammatory response syndrome: results of a prospective study. Am J Kidney Dis 2004;43(5):817-24.
Cekin Y, Cekin AH, Duman A, Yilmaz U, Yesil B, Yolcular BO. The role of serum procalcitonin levels in predicting Ascitic fluid infection in hospitalized cirrhotic and non-cirrhotic patients. Int J Med Sci 2013;10(10):1367-74.
Lee SH, Chan RC, Wu JY, Chen HW, Chang SS, Lee CC. Diagnostic value of procalcitonin for bacterial infection in elderly patients - a systemic review and meta-analysis. Int J Clin Pract 2013;67(12):1350-7.
Higashikawa T, Okuro M, Ishigami K, Mae K, Sangen R, Mizuno T, et al. Procalcitonin and albumin as prognostic biomarkers in elderly patients with a risk of bacterial infection. J Int Med Res 2018;46(7):2606-14.
Dinarello CA. Targeting the pathogenic role of interleukin 1β in the progression of smoldering/indolent myeloma to active disease. Mayo Clin Proc 2009;84(2):114–22.
Pepys MB, Hirschfield GM. C-reactive protein: a critical update. J Clin Invest 2003;111:1805-12.
Nargis W, Ibrahim M, Pepys MB, Hirschfield GM. C-reactive protein: a critical update. J Clin Invest 2003;111:1805-12.
Williams EJ, Mair L, de Silva TI, Green DJ, House P, Cawthron K, et al. Evaluation of procalcitonin as a contribution to antimicrobial stewardship in SARS-CoV-2 infection: a retrospective cohort study. J Hosp Infect 2021;110:103-07.
Romero Starke K, Reissig D, Petereit-Haack G, Schmauder S, Nienhaus A, Seidler A. The isolated effect of age on the risk of COVID-19 severe outcomes: a systematic review with meta-analysis. BMJ Glob Health 2021;6(12):e006434.
Hu R, Han C, Pei S, Yin M, Chen X. Procalcitonin levels in COVID-19 patients. Int J Antimicrob Agents 2020;56(2):106051.
Houghton R, Moore N, Williams R, El-Bakri F, Peters J, Mori M, et al. C-reactive protein-guided use of procalcitonin in COVID-19. JAC Antimicrob Resist 2021;3(4):dlab180.
Yusuf E, de Haan JE, van den Akker JPC, Vogel M, de Steenwinkel JEM, Rijnders BJA, et al. Increased number of positive coagulase-negative staphylococci in blood cultures is partly explained by increased use of intra-arterial catheters in patients with COVID-19. J Hosp Infect 2021;115:126-7.
Santoso P, Sung M, Hartantri Y, Andriyoko B, Sugianli AK, Alisjahbana B, et al. MDR Pathogens organisms as risk factor of mortality in secondary pulmonary bacterial infections among COVID-19 patients: observational studies in two referral hospitals in West Java, Indonesia. Int J Gen Med 2022;15:4741-51.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Journal of Preventive Medicine Association of Thailand
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
บทความที่ลงพิมพ์ในวารสารเวชศาสตร์ป้องกันแห่งประเทศไทย ถือเป็นผลงานวิชาการ งานวิจัย วิเคราะห์ วิจารณ์ เป็นความเห็นส่วนตัวของผู้นิพนธ์ กองบรรณาธิการไม่จำเป็นต้องเห็นด้วยเสมอไปและผู้นิพนธ์จะต้องรับผิดชอบต่อบทความของตนเอง